Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Ganesh Pawar Article rating: 4.1

The market opened flat on September 8, 2020, overall volumes in futures & options currently stand at 1,88,24,298 crore contracts with a turnover of Rs. 13,27,890.78 crore.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Ganesh Pawar Article rating: 3.8

The market opened flat on September 8, 2020, overall volumes in futures & options currently stand at 1,88,24,298 crore contracts with a turnover of Rs. 13,27,890.78 crore.

India air passenger traffic logs around 25 per cent MoM growth in August
India air passenger traffic logs around 25 per cent MoM growth in August

India air passenger traffic logs around 25 per cent MoM growth in August

Nidhi Jani Article rating: 5.0

Overall, the passenger traffic jumped by 19 per cent till August 31, with transporters flying over 70 lakh passengers during the period, after the reopening of services in a categorised way on domestic routes from May 25, following a two-month pause.

EIH Limited gains on fundraising approval of Rs 350 crore
EIH Limited gains on fundraising approval of Rs 350 crore

EIH Limited gains on fundraising approval of Rs 350 crore

Amir Shaikh Article rating: 4.6

The company's board of directors in a meeting held on September 7, 2020, has approved the raising of funds by the issuance and allotment of equity shares for up to an aggregate amount of up to Rs 350 crore

Dr Reddy announces launch of Fulvestrant injection
Dr Reddy announces launch of Fulvestrant injection

Dr Reddy announces launch of Fulvestrant injection

Amir Shaikh Article rating: 3.8

Dr Reddy informed the bourses on Monday that it has launched Fulvestrant injection, 250 mg/5 ml (50 mg/ml) per single-dose syringe, a therapeutic equivalent generic version of Faslodex (fulvestrant) injection, 250 mg/5 ml (50 mg/ml), approved by United States Food & Drug Administration (USFDA)

RSS
First21192120212121222124212621272128Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR